🇺🇸 FDA
Patent

US 10556890

Heteroaryl compounds and methods of use thereof

granted A61PA61P1/08A61P15/00

Quick answer

US patent 10556890 (Heteroaryl compounds and methods of use thereof) held by PGI Drug Discovery LLC expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PGI Drug Discovery LLC
Grant date
Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P1/08, A61P15/00, A61P15/10, A61P25/00